Reports credit the huge turnaround to various factors. Most focused on Dharavi’s use of widespread testing and contact tracing. One is the use of an anti-malarial drug. But they ignored the policy most responsible. Indian doctors used hydroxychloroquine (HCQ) for prophylaxis (preventive) treatment — the same drug the American media have politicized.
Dharavi’s COVID-19 infection rate dropped drastically from April through June. In July, new infections were very low, almost reaching zero on July 9.
Officials have credited this turnaround to “[a] combination of hydroxychloroquine, vitamin D, and zinc tablets along with homeopathic medicines.”